πŸ‡ΊπŸ‡Έ FDA
Patent

US 12161648

Covalent targeting of E3 ligases

granted A61KA61K31/365A61K31/4535

Quick answer

US patent 12161648 (Covalent targeting of E3 ligases) held by The Regents of the University of California expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/365, A61K31/4535, A61K31/551, A61K47/55